1/5
04:01 pm
cycn
Cyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126 in Treatment-Resistant Depression
Medium
Report
Cyclerion Therapeutics Announces Strategic Agreement with Medsteer and Progress Toward Initiating Phase 2 Proof-of-Concept Study for CYC-126 in Treatment-Resistant Depression
12/2
03:41 pm
cycn
Cyclerion Therapeutics (NASDAQ:CYCN) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Cyclerion Therapeutics (NASDAQ:CYCN) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/10
10:26 am
cycn
EXCLUSIVE: Cycurion Wins $1 Million+ Contract To Modernize Federal Emergency Warning Network [Yahoo! Finance]
Medium
Report
EXCLUSIVE: Cycurion Wins $1 Million+ Contract To Modernize Federal Emergency Warning Network [Yahoo! Finance]